The future of pulmonary function testing

Respiratory Care

Volumn 57, Issue 1, 2012, Pages 154-164

  MacIntyre, Neil R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

PFT; Pulmonary function testing

Indexed keywords

BIOLOGICAL MARKER;

ACOUSTIC TECHNOLOGY; ARTICLE; BREATH ANALYSIS; CERTIFICATION; CLINICAL DECISION MAKING; ECHOCARDIOGRAPHY; HEART OUTPUT; HUMAN; LABORATORY DEVICE; LUNG FUNCTION TEST; LUNG GAS EXCHANGE; LUNG MECHANICS; LUNG VENTILATION PERFUSION RATIO; MEDICAL EDUCATION; NON INVASIVE MEASUREMENT; OXYGEN TISSUE LEVEL; QUALITY CONTROL; TISSUE OXYGENATION;

ALGORITHMS; BIOLOGICAL MARKERS; CARDIAC OUTPUT; FORECASTING; HUMANS; OXYGEN; OXYGEN CONSUMPTION; PULMONARY GAS EXCHANGE; RESPIRATORY FUNCTION TESTS;

EID: 84856789489     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01422     Document Type: Article

References (46)

1. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948-968.
2. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al; ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J 2005;26(1):153-161.
3. American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 1986;133:1205-1209.
4. Global Initiative for Chronic Obstructive Lung Disease. Guidelines and resources. http://www.goldcopd.org/Guidelines/guidelinesresources. html. Accessed November 2, 2011.
5. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the first National Health and Nutrition Examination Survey follow-up. Thorax 2003;58(5):388-393.
6. Celli BR. Predictors of mortality in COPD. Respir Med 2010;104(6):773-779.
7. Neas LM, Schwartz J. Pulmonary function levels as predictors of mortality in a national sample of US adults. Am J Epidemiol 1998;147(11):1011-1018.
8. Smetana GW, Lawrence VA, Cornell JE. Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Int Med 2006;144(8):581-595.
9. Miller JI. Physiologic evaluation of pulmonary function in the candidate for lung resection. J Thorac Cardiovasc Surg 1993;105(2):347-351.
10. Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiological variables predict survival in pulmonary fibrosis. Am J Respir Crit Care Med 2003;168(5):538-542.
11. Berry CE. Wise RA. Mortality in COPD: causes, risk factors, and prevention. J COPD 2010;7(5):375-382.
12. Kangalee KM, Abboud RT. Interlaboratory and intralaboratory variability in pulmonary function testing: a 13 year study using a normal biologic control. Chest 1992;101(1):88-92.
13. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, et al; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338.
14. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26(3):511-522.
15. MacIntyre NR, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26(4):720-735.
16. Crapo RO. Jensen RL. Standards and interpretive issues in lung function testing. Respir Care 2003;48(8):764-772.
17. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144(5):1202-1218.
18. Jensen RL, Crapo RO, Flint AK, et al. Problems in selecting representative reference values for spirometry (abstract). Am J Respir Crit Care Med 2002;165:A200.
19. Jensen RL, Teeter JG, England RD, Howell HM, White HJ, Pickering EH, Crapo RO. Sources of long-term variability in measurements of lung function: implications for interpretation and clinical trial design. Chest 2007;132(2):396-402.
20. Collen J, Greenburg D, Holley A, King CS, Hnatiuk O. Discordance in spirometric interpretations using three commonly used reference equations vs national health and nutrition examination study III. Chest 2008;134(5):1009-1016.
21. White P, Wong W, Fleming T, Gray B. Primary care spirometry: test quality and the feasibility and usefulness of specialist reporting. Brit J Gen Pract 2007;57(542):701-705.
22. Davies J, Crapo RO, MacIntyre NR; ATS Pulmonary Function Laboratory Registry. Pulmonary function testing interpretation and report generation is a slow, cumbersome, and inefficient process (abstract). Respir Care 2005;50(11).
23. Damarla M, Celli BR, Mullerova Hx, et al. Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure. Respir Care 2006;51:1120-1124.
24. MacIntyre NR, Selecky PA. Is there a role for screening spirometry? Respir Care 2010;55(1):35-40.
25. Vedal S, Crapo RO. False positive rates of multiple pulmonary function tests in healthy subjects. Bull Eur Physiopathol Respir 1983;19(3):263-266.
26. Hall GL, Sly PD, Fukushima T, Kusel MM, Franklin PJ, Horak F Jr, et al. Respiratory function in healthy young children using forced oscillations. Thorax 2007;62(6):521-526.
27. LCO but no restrictive ventilator defect in sarcoidosis. Eur Respir J 2010;36(6):1315-1322.
28. Hayot M, Ramonatxo M, Matecki S, Milic-Emili J, Prefaut C. Noninvasive assessment of inspiratory muscle function during exercise. Am J Respir Crit Care Med 2000;162(6):2201-2207.
29. Barker SJ, Badal JJ. The measurement of dyshemoglobins and total hemoglobin by pulse oximetry. Curr Opin Anaesth 2008;21(6):805-810.
30. Nishiguchi BK, Yu M, Suetsugu A, Jiang C, Takiguchi SA, Takanishi DM Jr. Determination of reference ranges for transcutaneous oxygen and carbon dioxide tension and the oxygen challenge test in healthy and morbidly obese subjects. J Surg Res 2008;150(2):204-211.
31. Stokes DL, MacIntyre NR, Nadel JA. Nonlinear increases in diffusing capacity during exercise in the sitting and supine position. J Appl Physiol 1981;51(4):858-863.
32. Huang YC, O'Brien SR, MacIntyre NR. Intrabreath diffusing capacity of the lungs in healthy individuals at rest and at exercise. Chest 2002;122(1):177-185.
33. van der Lee I, Zanen P, Grutters JC, Snijder RJ, van den Bosch JM. Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension. Chest 2006;129(2):378-383.
34. de Waal EE, Wappler F, Buhre WF. Cardiac output monitoring. Curr Opin Anaesth 2009;22(1):71-77.
35. Kharitonov SA, Barnes PJ. Exhaled biomarkers. Chest 2006;130(5):1541-1546.
36. Tseliou E, Bessa V, Hillas G, Delimpoura V, Papadaki G, Roussos C, et al. Exhaled nitric oxide and exhaled breath condensate pH in severe refractory asthma. Chest 2010;138(1):107-113.
37. O'Reilly P, Bailey W. Clinical use of exhaled biomarkers in COPD. Intern J COPD 2007;2(4):403-408.
38. Wagner PD. The multiple inert gas elimination technique (MIGET). Intensive Care Med 2008;34(6):994-1001.
39. Highton D, Elwell C, Smith M. Noninvasive cerebral oximetry: is there light at the end of the tunnel? Curr Opin Anaesth 2010;23(5):576-581.
40. Elphick HE, Lancaster GA, Solis A, Majumadar A, Gupta R, Smyth RL. Validity and reliability of acoustic analysis of respiratory sounds in infants. Arch Dis Child 2004;89(11):1059-1063.
41. Elphick HE, Ritson S, Rodgers H, Everard ML. When a "wheeze" is not a wheeze: acoustic analysis of breath sounds in infants. Eur Respir J 2000;15:593-597.
42. Muders T, Luepschen H, Putensen C. Impedance tomography as a new monitoring technique. Curr Opin Crit Care 2010;16(3):269-275.
43. Antus B, Barta I, Kullmann T, Lázár Z, Valyon M, Horváth I, Csiszer E. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease. A longitudinal study. Am J Respir Crit Care Med 2010;182(12):1492-1497.
44. Horváth I, Lázár Z, Gyulai N, Kollai M, Losonczy G. Exhaled biomarkers in lung cancer. Eur Respir J 2009;34(1):261-275.
45. Van Muylem A, Knoop C, Estenne M. Early detection of chronic pulmonary allograft dysfunction by exhaled biomarkers. Am J Respir Care 2007;175(7):731-736.
46. Effros RM. Exhaled breath condensates: delusion or dilution? Chest 2010;138(3):471-472.